Halozyme Therapeutics' IPO

Halozyme Therapeutics raised a round of funding on May 10, 2007. Investors include Public.

Halozyme (NASDAQ: HALO) is a biopharmaceutical company developing and commercializing products based on the extracellular matrix for the drug delivery, oncology, and dermatology markets.…

Articles about Halozyme Therapeutics' IPO: